Trial Profile
Chemoprevention of Skin Cancers With DFMO [eflornithine]: A Controlled, Randomized Clinical Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Sep 2005
Price :
$35
*
At a glance
- Drugs Eflornithine (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- 18 Sep 2005 New trial record.